Suppr超能文献

绿色荧光蛋白标记的雄激素受体在活的前列腺癌细胞系和非前列腺癌细胞系中的差异配体介导反应。

A differential ligand-mediated response of green fluorescent protein-tagged androgen receptor in living prostate cancer and non-prostate cancer cell lines.

作者信息

Nakauchi Hiroo, Matsuda Ken-ichi, Ochiai Ikuo, Kawauchi Akihiro, Mizutani Yoichi, Miki Tsuneharu, Kawata Mitsuhiro

机构信息

Department of Urology, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto 602-8566, Japan.

出版信息

J Histochem Cytochem. 2007 Jun;55(6):535-44. doi: 10.1369/jhc.6A7064.2007. Epub 2007 Feb 20.

Abstract

Androgen has been shown to promote the proliferation of prostate cancer through the action of the androgen receptor (AR). Mutation (T877A) of the AR gene found in an androgen-sensitive prostate cancer cell line, LNCaP, has been postulated to be involved in hypersensitivity and loss of specificity for androgen. In the present study, trafficking of AR and AR (T877A) in living prostate and non-prostate cancer cell lines under high and low concentrations of androgen and antiandrogen was investigated by tagging green fluorescent protein (GFP) to the receptors. In the presence of a high concentration of androgen, AR-GFP localized in the nucleus by forming discrete clusters in all cell lines. AR (T877A)-GFP was also translocated to the nucleus in LNCaP and COS-1 cells by the addition of a high concentration of androgen. In contrast, in the presence of a low concentration of androgen, the translocation of AR-GFP and AR (T877A)-GFP was observed in LNCaP cells, but not in COS-1 cells. Upon the addition of antiandrogen, AR-GFP was translocated to the nucleus but did not form subnuclear foci in both COS-1 and LNCaP cells, whereas AR (T877A)-GFP in both cells was translocated to the nucleus with subnuclear foci. The present study demonstrates the differential response of nuclear trafficking of AR and its mutant in prostate cancer cell lines and COS cells, and the subcellular and subnuclear compartmentalization provide important information on the sensitivity of the AR mutation.

摘要

雄激素已被证明可通过雄激素受体(AR)的作用促进前列腺癌的增殖。在雄激素敏感的前列腺癌细胞系LNCaP中发现的AR基因突变(T877A),被认为与雄激素的超敏反应和特异性丧失有关。在本研究中,通过将绿色荧光蛋白(GFP)标记到受体上,研究了高、低浓度雄激素和抗雄激素作用下,AR和AR(T877A)在活的前列腺癌细胞系和非前列腺癌细胞系中的转运情况。在高浓度雄激素存在的情况下,AR-GFP在所有细胞系中通过形成离散的簇定位于细胞核。通过添加高浓度雄激素,AR(T877A)-GFP在LNCaP和COS-1细胞中也转运到细胞核。相比之下,在低浓度雄激素存在的情况下,在LNCaP细胞中观察到了AR-GFP和AR(T877A)-GFP的转运,但在COS-1细胞中未观察到。添加抗雄激素后,AR-GFP在COS-1和LNCaP细胞中均转运到细胞核,但未形成核内小体,而两种细胞中的AR(T877A)-GFP均转运到细胞核并形成核内小体。本研究证明了前列腺癌细胞系和COS细胞中AR及其突变体核转运的差异反应,其亚细胞和核内分隔为AR突变的敏感性提供了重要信息。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验